Sangeeta Kashyap
Overview
Explore the profile of Sangeeta Kashyap including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
2087
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Sinha Gregory N, Andreopoulou P, Kashyap S, Cusano N
J Clin Endocrinol Metab
. 2024 Sep;
110(3):e868-e877.
PMID: 39319404
Normocalcemic primary hyperparathyroidism (NPHPT), a phenotype of primary hyperparathyroidism, is characterized by elevated parathyroid hormone levels in the setting of persistently normal serum calcium. Diagnosis of NPHPT can be challenging...
2.
Mehta N, Huey S, Kuriyan R, Pena-Rosas J, Finkelstein J, Kashyap S, et al.
Adv Nutr
. 2024 Feb;
15(3):100186.
PMID: 38316343
Precision nutrition (PN) considers multiple individual-level and environmental characteristics or variables to better inform dietary strategies and interventions for optimizing health, including managing obesity and metabolic disorders. Here, we review...
3.
Sadana P, Edler M, Aghayev M, Arias-Alvarado A, Cohn E, Ilchenko S, et al.
Am J Physiol Endocrinol Metab
. 2022 Oct;
323(6):E480-E491.
PMID: 36223521
Several aspects of diabetes pathophysiology and complications result from hyperglycemia-induced alterations in the structure and function of plasma proteins. Furthermore, insulin has a significant influence on protein metabolism by affecting...
4.
Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey W, et al.
Endocr Pract
. 2022 May;
28(5):528-562.
PMID: 35569886
Objective: To provide evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other...
5.
Mauer Y, Parker M, Kashyap S
Cleve Clin J Med
. 2021 Dec;
88(12):658-659.
PMID: 34857602
No abstract available.
6.
Mauer Y, Parker M, Kashyap S
Cleve Clin J Med
. 2021 Dec;
88(12):657-658.
PMID: 34857600
No abstract available.
7.
Ferraz-Bannitz R, Kashyap S, Patti M
J Clin Endocrinol Metab
. 2021 Sep;
107(2):e883-e885.
PMID: 34543416
No abstract available.
8.
Burguera B, Pantalone K, Griebeler M, Lansang M, Rao P, Kashyap S, et al.
Endocr Pract
. 2021 Jan;
26(7):794-796.
PMID: 33471649
No abstract available.
9.
Lawrence L, Menon V, Kashyap S
Curr Cardiol Rep
. 2018 Jun;
20(8):65.
PMID: 29926285
Purpose Of Review: We review the cardiovascular and renal outcomes and safety of newer anti-diabetic medications in high-risk patients. We examine the outcomes of the IRIS, EMPA-REG OUTCOME, CANVAS, LEADER,...
10.
Miranda E, Somal V, Mey J, Blackburn B, Wang E, Farabi S, et al.
Am J Physiol Endocrinol Metab
. 2017 Aug;
313(6):E631-E640.
PMID: 28811295
The soluble receptor for advanced glycation end products (sRAGE) may be protective against inflammation associated with obesity and type 2 diabetes (T2DM). The aim of this study was to determine...